letrozole has been researched along with Diabetic Nephropathies in 1 studies
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makary, S | 1 |
| Abdo, M | 1 |
| Hassan, WA | 1 |
| Tawfik, MK | 1 |
1 other study available for letrozole and Diabetic Nephropathies
| Article | Year |
|---|---|
Angiotensin blockade attenuates diabetic nephropathy in hypogonadal adult male rats.
Topics: Angiotensin II; Angiotensins; Animals; Collagen Type IV; Diabetic Nephropathies; Estradiol; Follicle | 2019 |